PHARMAD
ActiveSummary
PHARMAD has been active since 2013 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20,000 and a net result of €144,837. Equity remains stable across the filed financial years (±0.2% per year). Its solvency ranks better than 10% of 10,757 sector peers (NACE 70, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).
History
Acts, filings and financial milestones
Next filing, financial year 2026, expected by
2026
27-01
NBB filing
Annual accounts filed
financial year 2025 · abbreviated format
2025
31-01
NBB filing
Annual accounts filed
financial year 2024 · abbreviated format
2024
30-06
Financial
Equity above €500,000equity €563,396 ▲28.8%
A profit in every financial year since 2019 builds equity to €563,396.
30-01
NBB filing
Annual accounts filed
financial year 2023 · abbreviated format
2023
25-07
Gazette deed
Reappointments: Mattias THUYSBAERT (director) and Adelinde DIERICK (director)Capital conversion · Amendment of the articles · Registered office clause12 facts ▸
Gazette deed
Reappointments: Mattias THUYSBAERT (director) and Adelinde DIERICK (director)
Capital conversion · Amendment of the articles · Registered office clause12 facts ▸
- General meeting, 10-07-2023
- Other provision, “aanpassing statuten aan WVV en behoud rechtsvorm, statuten aanpassen aan WVV” (deed in Dutch)
- Capital conversion, “Onbeschikbare inbreng buiten kapitaal - Andere, Statutair onbeschikbare reserves” (deed in Dutch)
- Other provision, “Beschikbare inbreng buiten kapitaal - Andere, Beschikbare reserves” (deed in Dutch)
- Other provision, “vermelding onbeschikbare rekening in statuten, statutair onbeschikbare eigen vermogensrekening moet niet vermeld worden in de statuten” (deed in Dutch)
- Amendment of the articles (2 times)
- Director reappointment, Mattias THUYSBAERT (director (not named in the articles))
- Director reappointment, Adelinde DIERICK (director (not named in the articles))
- Other provision, “kwijting aan zaakvoerders (bestuurders), vergadering zal op volgende jaarvergadering beslissen over kwijting voor uitoefening mandaat” (deed in Dutch)
- Registered office clause, “8550 Zwevegem, Ommegangstraat 4” (deed in Dutch)
- Other provision, “coördinatie statuten, opdracht aan instrumenterende notaris om statuten te coördineren” (deed in Dutch)
- Power of attorney, ACCOFISC (2 times)
30-06
Financial
Highest result from 2019 to 2025net €146,571 ▲53.1%
Operating result €198,108, net result €146,571, both a record.
31-01
NBB filing
Annual accounts filed
financial year 2022 · abbreviated format
2022
24-01
NBB filing
Annual accounts filed
financial year 2021 · abbreviated format
2021
30-06
Financial
Equity above €500,000equity €525,192 ▲8.8%
A profit in every financial year since 2019 builds equity to €525,192.
2020
22-12
NBB filing
Annual accounts filed
financial year 2020 · abbreviated format
2019
19-12
NBB filing
Annual accounts filed
financial year 2019 · abbreviated format
10-01
NBB filing
Annual accounts filed
financial year 2018 · abbreviated format
2017
21-12
NBB filing
Annual accounts filed
financial year 2017 · abbreviated format
12-01
NBB filing
Annual accounts filed
financial year 2016 · abbreviated format
Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 11 annual accounts filed, the latest 10 are here; all 11 are under Financials.
1 of 2 deeds read
About the unread acts
Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.